Bioniche Life Sciences Inc. Regains Sponsorship of Urocidin™

Published April 18, 2013

Bioniche Life Sciences Inc. Regains Sponsorship of Urocidin™
Filed under: journal of dual diagnosis

About UrocidinTM. Urocidin™ is a formulation of MCC, a sterile mycobacterial cell wall-DNA complex composition that has a dual mode of action: immune stimulation and direct anticancer activity. UrocidinTM is formulated for the treatment of bladder …
{Source}

Amorfix Chief Science Officer to present latest on ovarian cancer therapeutic …
Filed under: journal of dual diagnosis

Ovarian cancer is often not diagnosed until late-stage disease when the cancer has spread to other organs in the body, which contributes to the short survival time following diagnosis. Ovarian cancer is typically treated with surgery and chemotherapy.
{Source}